NAA25

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, NAA25 mutation is significantly associated with the drug of many other genes, with 16 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible NAA25-associated genes across cancer lineages are Quizartinib, 150412, and Sinularin. Each is linked with NAA25 in more than 1 cancer types. Because this analysis shows association rather than direction, both NAA25-to-partner and partner-to-NAA25 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Quizartinib grouped by NAA25-low versus NAA25-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NAA25→partner) and Y-score (partner→NAA25) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEQuizartinib →+0.428+2.652.007.04531
LARGE_INTESTINE150412 →+0.440+2.777.008.03821
LARGE_INTESTINESinularin →+0.442+2.777.004.03821
LARGE_INTESTINENutlin-3a (-) →+0.727+2.646.048.04711
LARGE_INTESTINEPFI3 →+0.263+2.646.024.04711
LARGE_INTESTINEPCI-34051 →+0.460+2.646.016.04711
Each partner links to its Q-omics profile. Showing the 6 strongest of 16 associations by consensus.

Quizartinib by NAA25 expression — LARGE_INTESTINE

Box plot of Quizartinib in NAA25-low vs NAA25-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration